Suppr超能文献

加拿大肝细胞癌的一项流行病学研究。

An epidemiologic study of hepatocellular carcinoma in Canada.

作者信息

elSaadany Susie, Tepper Martin, Mao Yang, Semenciw Robert, Giulivi Antonio

机构信息

Health-Care Acquired Infections Division, Health Canada.

出版信息

Can J Public Health. 2002 Nov-Dec;93(6):443-6. doi: 10.1007/BF03405035.

Abstract

BACKGROUND AND METHODS

To provide information on poorly described Canadian hepatocellular cancer epidemiology, we analyzed incident cases abstracted from the Canadian Cancer Registration Database (1969-1997) and Canadian annual death data (1969-1998). Age, sex, geographic distribution, and secular trends were described. Projection models were developed for the next decade.

RESULTS

Results indicated much higher incidence and mortality rates in males than females, with substantial increases for both with age. Age-standardized incidence rates increased an average of 3.4% per year in males, 1.2% per year in females (1969-1997). Age-standardized mortality rates increased an average of 1.48% in males, but decreased an average of 0.46% per year in females (1969-1998). Join-point analysis of the linear trends in the age-standardized incidence and mortality rates suggested that a new trend started to emerge about 1991. The fitted non-linear multiplicative model predicted the occurrence of 1,565 new cases and 802 deaths in the year 2010. HCC incidence was the highest in British Colombia, followed by Quebec, and the lowest in the Atlantic region.

CONCLUSIONS

Incidence rates of hepatocellular carcinoma have increased substantially, consistent with the reported increase in the prevalence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) infections in recent decades.

摘要

背景与方法

为提供关于描述不足的加拿大肝细胞癌流行病学信息,我们分析了从加拿大癌症登记数据库(1969 - 1997年)提取的发病病例以及加拿大年度死亡数据(1969 - 1998年)。描述了年龄、性别、地理分布和长期趋势。并建立了未来十年的预测模型。

结果

结果表明男性的发病率和死亡率远高于女性,且两者均随年龄大幅上升。年龄标准化发病率在男性中平均每年增加3.4%,在女性中平均每年增加1.2%(1969 - 1997年)。年龄标准化死亡率在男性中平均每年增加1.48%,但在女性中平均每年下降0.46%(1969 - 1998年)。对年龄标准化发病率和死亡率的线性趋势进行的连接点分析表明,大约在1991年开始出现新的趋势。拟合的非线性乘法模型预测2010年将出现1565例新发病例和8例死亡。肝细胞癌发病率在不列颠哥伦比亚省最高,其次是魁北克省,在大西洋地区最低。

结论

肝细胞癌发病率大幅上升,这与近几十年来丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)感染患病率的报告增加相一致。

相似文献

1
An epidemiologic study of hepatocellular carcinoma in Canada.
Can J Public Health. 2002 Nov-Dec;93(6):443-6. doi: 10.1007/BF03405035.
2
Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
J Viral Hepat. 2011 Jul;18(7):e232-41. doi: 10.1111/j.1365-2893.2011.01440.x. Epub 2011 Feb 17.
3
Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival.
Liver Int. 2019 Mar;39(3):522-530. doi: 10.1111/liv.13966. Epub 2018 Nov 5.
4
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
Oncogene. 2006 Jun 26;25(27):3771-7. doi: 10.1038/sj.onc.1209560.
7
Trends in incidence of hepatocellular carcinoma, 1990-2009, Khon Kaen, Thailand.
Asian Pac J Cancer Prev. 2012;13(3):1065-8. doi: 10.7314/apjcp.2012.13.3.1065.

引用本文的文献

1
Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
PLoS One. 2016 Apr 19;11(4):e0153863. doi: 10.1371/journal.pone.0153863. eCollection 2016.
3
Evidence-based clinical guidelines for immigrants and refugees.
CMAJ. 2011 Sep 6;183(12):E824-925. doi: 10.1503/cmaj.090313. Epub 2010 Jun 7.
5
Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon.
Mol Biol Rep. 2009 Feb;36(2):381-8. doi: 10.1007/s11033-007-9191-2. Epub 2007 Dec 5.
7
VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication.
World J Gastroenterol. 2005 Nov 7;11(41):6429-32. doi: 10.3748/wjg.v11.i41.6429.
8
Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C.
Int Semin Surg Oncol. 2005 Oct 4;2:20. doi: 10.1186/1477-7800-2-20.
9
Anti-HBV activity of TRL mediated by recombinant adenovirus.
World J Gastroenterol. 2005 May 7;11(17):2574-8. doi: 10.3748/wjg.v11.i17.2574.
10
Inhibition of HBV targeted ribonuclease enhanced by introduction of linker.
World J Gastroenterol. 2003 Jul;9(7):1504-7. doi: 10.3748/wjg.v9.i7.1504.

本文引用的文献

1
Current status of hepatitis C in Canada.
Can J Public Health. 2000 Jul-Aug;91 Suppl 1(Suppl 1):S10-5, S10-6. doi: 10.1007/BF03405100.
2
Prediction of hepatitis C burden in Canada.
Can J Gastroenterol. 2000 Jul-Aug;14(7):575-80. doi: 10.1155/2000/642707.
3
Do drinking surveys predict changes in population-based alcohol problem indicators?
Alcohol Alcohol. 2000 May-Jun;35(3):255-8. doi: 10.1093/alcalc/35.3.255.
5
Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators?
Annu Rev Public Health. 1999;20:173-209. doi: 10.1146/annurev.publhealth.20.1.173.
6
Rising incidence of hepatocellular carcinoma in the United States.
N Engl J Med. 1999 Mar 11;340(10):745-50. doi: 10.1056/NEJM199903113401001.
7
Treatment, Alcoholics Anonymous and alcohol controls during the decrease in alcohol problems in Alberta: 1975-1993.
Alcohol Alcohol. 1998 May-Jun;33(3):265-72. doi: 10.1093/oxfordjournals.alcalc.a008390.
8
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.
Int J Cancer. 1998 Jan 30;75(3):347-54. doi: 10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2.
9
Trends in primary liver cancer.
Lancet. 1998 Jan 17;351(9097):214-5. doi: 10.1016/S0140-6736(05)78179-4.
10
Screening for hepatocellular carcinoma.
Hepatology. 1998 Jan;27(1):273-8. doi: 10.1002/hep.510270140.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验